MARCKS and plasma cell myeloma: A subsequent study by Muguruma et al. corroborated our findings and further demonstrated a unique molecular mechanism that involves the bone marrow myeloma niche cells-localized Jagged1-induced activation of the Notch/PKC pathway that subsequently phosphorylates MARCKS and enhances its involvement in the development of drug-resistance in MM [18].